Clinical Study of Vaginal Lactobacilli and Estriol (Gynoflor®) for Atrophic Vaginitis in Breast Cancer Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Atrophic Vaginitis
Interventions
DRUG

Estriol 0.03 mg, lyophylized lactobacillus

Vaginal tablet with lyophilised lactobacilli and 0.03 mg estriol; Once daily for 28 days then 3 times per week for 8 weeks;

Trial Locations (2)

Unknown

University Hospital Leuven, Leuven

Department of Obstetrics and Gynaecology, University of Regensburg, Regensburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medinova AG

INDUSTRY

NCT01370551 - Clinical Study of Vaginal Lactobacilli and Estriol (Gynoflor®) for Atrophic Vaginitis in Breast Cancer Patients | Biotech Hunter | Biotech Hunter